Cargando…
Low Oral Bioavailability and Partial Gut Microbiotic and Phase II Metabolism of Brussels/Witloof Chicory Sesquiterpene Lactones in Healthy Humans
Free and glycosylated sesquiterpene lactones (SLs), which are abundant in leafy vegetables including Brussels/witloof chicory, possess health-promoting effects in vivo. However, the pharmacokinetics of dietary source of SLs remain largely unknown. In this open-label and single-dose trial, sixteen he...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760865/ https://www.ncbi.nlm.nih.gov/pubmed/33260567 http://dx.doi.org/10.3390/nu12123675 |
_version_ | 1783627433815048192 |
---|---|
author | Weng, Hui He, Luanying Zheng, Jiakun Li, Qing Liu, Xiuping Wang, Dongliang |
author_facet | Weng, Hui He, Luanying Zheng, Jiakun Li, Qing Liu, Xiuping Wang, Dongliang |
author_sort | Weng, Hui |
collection | PubMed |
description | Free and glycosylated sesquiterpene lactones (SLs), which are abundant in leafy vegetables including Brussels/witloof chicory, possess health-promoting effects in vivo. However, the pharmacokinetics of dietary source of SLs remain largely unknown. In this open-label and single-dose trial, sixteen healthy volunteers consumed 150 g of Brussels/witloof chicory juice containing 48.77 μmol SLs in 5 min. Blood, urine, and fecal samples were collected before and after chicory consumption in 24 h. No SLs were detected in the serum, urine, and fecal samples before chicory consumption in all of the participants. Chicory consumption increased lactucin, 11β,13-dihydrolactucin, and their glucuronide/sulfate conjugates, rather than lactucopicrin and 11β,13-dihydrolactucopicrin, as well as glycosylated SLs in biological samples. The peak concentration of total SLs in serum reached 284.46 nmol/L at 1 h, while, in urine, this peak was 220.3 nmol between 2 and 6 h. The recovery of total SLs in blood, urine, and feces was 7.03%, 1.13%, and 43.76% of the ingested dose, respectively. Human fecal suspensions with intestinal microbiota degraded glycosylated SLs in chicory, and converted lactucopicrin and 11β,13-dihydrolactucopicrin to lactucin and 11β,13-dihydrolactucin, respectively. Collectively, Brussels/witloof chicory SLs are poorly bioavailable and they undergo partial gut microbial and phase II metabolism in humans. |
format | Online Article Text |
id | pubmed-7760865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77608652020-12-26 Low Oral Bioavailability and Partial Gut Microbiotic and Phase II Metabolism of Brussels/Witloof Chicory Sesquiterpene Lactones in Healthy Humans Weng, Hui He, Luanying Zheng, Jiakun Li, Qing Liu, Xiuping Wang, Dongliang Nutrients Article Free and glycosylated sesquiterpene lactones (SLs), which are abundant in leafy vegetables including Brussels/witloof chicory, possess health-promoting effects in vivo. However, the pharmacokinetics of dietary source of SLs remain largely unknown. In this open-label and single-dose trial, sixteen healthy volunteers consumed 150 g of Brussels/witloof chicory juice containing 48.77 μmol SLs in 5 min. Blood, urine, and fecal samples were collected before and after chicory consumption in 24 h. No SLs were detected in the serum, urine, and fecal samples before chicory consumption in all of the participants. Chicory consumption increased lactucin, 11β,13-dihydrolactucin, and their glucuronide/sulfate conjugates, rather than lactucopicrin and 11β,13-dihydrolactucopicrin, as well as glycosylated SLs in biological samples. The peak concentration of total SLs in serum reached 284.46 nmol/L at 1 h, while, in urine, this peak was 220.3 nmol between 2 and 6 h. The recovery of total SLs in blood, urine, and feces was 7.03%, 1.13%, and 43.76% of the ingested dose, respectively. Human fecal suspensions with intestinal microbiota degraded glycosylated SLs in chicory, and converted lactucopicrin and 11β,13-dihydrolactucopicrin to lactucin and 11β,13-dihydrolactucin, respectively. Collectively, Brussels/witloof chicory SLs are poorly bioavailable and they undergo partial gut microbial and phase II metabolism in humans. MDPI 2020-11-28 /pmc/articles/PMC7760865/ /pubmed/33260567 http://dx.doi.org/10.3390/nu12123675 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Weng, Hui He, Luanying Zheng, Jiakun Li, Qing Liu, Xiuping Wang, Dongliang Low Oral Bioavailability and Partial Gut Microbiotic and Phase II Metabolism of Brussels/Witloof Chicory Sesquiterpene Lactones in Healthy Humans |
title | Low Oral Bioavailability and Partial Gut Microbiotic and Phase II Metabolism of Brussels/Witloof Chicory Sesquiterpene Lactones in Healthy Humans |
title_full | Low Oral Bioavailability and Partial Gut Microbiotic and Phase II Metabolism of Brussels/Witloof Chicory Sesquiterpene Lactones in Healthy Humans |
title_fullStr | Low Oral Bioavailability and Partial Gut Microbiotic and Phase II Metabolism of Brussels/Witloof Chicory Sesquiterpene Lactones in Healthy Humans |
title_full_unstemmed | Low Oral Bioavailability and Partial Gut Microbiotic and Phase II Metabolism of Brussels/Witloof Chicory Sesquiterpene Lactones in Healthy Humans |
title_short | Low Oral Bioavailability and Partial Gut Microbiotic and Phase II Metabolism of Brussels/Witloof Chicory Sesquiterpene Lactones in Healthy Humans |
title_sort | low oral bioavailability and partial gut microbiotic and phase ii metabolism of brussels/witloof chicory sesquiterpene lactones in healthy humans |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760865/ https://www.ncbi.nlm.nih.gov/pubmed/33260567 http://dx.doi.org/10.3390/nu12123675 |
work_keys_str_mv | AT wenghui loworalbioavailabilityandpartialgutmicrobioticandphaseiimetabolismofbrusselswitloofchicorysesquiterpenelactonesinhealthyhumans AT heluanying loworalbioavailabilityandpartialgutmicrobioticandphaseiimetabolismofbrusselswitloofchicorysesquiterpenelactonesinhealthyhumans AT zhengjiakun loworalbioavailabilityandpartialgutmicrobioticandphaseiimetabolismofbrusselswitloofchicorysesquiterpenelactonesinhealthyhumans AT liqing loworalbioavailabilityandpartialgutmicrobioticandphaseiimetabolismofbrusselswitloofchicorysesquiterpenelactonesinhealthyhumans AT liuxiuping loworalbioavailabilityandpartialgutmicrobioticandphaseiimetabolismofbrusselswitloofchicorysesquiterpenelactonesinhealthyhumans AT wangdongliang loworalbioavailabilityandpartialgutmicrobioticandphaseiimetabolismofbrusselswitloofchicorysesquiterpenelactonesinhealthyhumans |